Inventor
PEARSALL ROBERT SCOTT
US26 patents
⚠️ This page may combine multiple inventors who share the name “PEARSALL ROBERT SCOTT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACCELERON PHARMA INC
23 patentsUS8361957B2Jan 29, 2013
Isolated GDF trap polypeptide
ACCELERON PHARMA INC42 citations98
US10377996B2Aug 13, 2019
Methods of identifying ActRIIB variants
ACCELERON PHARMA INC24 citations94
US10131700B2Nov 20, 2018
Methods for treating refractory anemia with ringed sideroblasts
ACCELERON PHARMA INC20 citations94
US9932379B2Apr 3, 2018
Isolated nucleotide sequences encoding GDF traps
ACCELERON PHARMA INC19 citations94
US9505813B2Nov 29, 2016
Use of GDF traps to treat anemia
ACCELERON PHARMA INC20 citations92
US9439945B2Sep 13, 2016
Isolated nucleotide sequences encoding GDF traps
ACCELERON PHARMA INC18 citations92
US11028145B2Jun 8, 2021
ALK7:actriib heteromultimers and uses thereof
ACCELERON PHARMA INC4 citations84
US10889626B2Jan 12, 2021
Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
ACCELERON PHARMA INC4 citations84
US10829532B2Nov 10, 2020
Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
ACCELERON PHARMA INC4 citations84
US10738098B2Aug 11, 2020
ALK4:ActRIIB heteromultimers and uses thereof
ACCELERON PHARMA INC6 citations84
US10689427B2Jun 23, 2020
Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
ACCELERON PHARMA INC7 citations84
US10227393B2Mar 12, 2019
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof
ACCELERON PHARMA INC9 citations84
US11279746B2Mar 22, 2022
ALK4:ActRIIB heteromultimers and uses thereof
ACCELERON PHARMA INC2 citations73
US10906958B2Feb 2, 2021
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof
ACCELERON PHARMA INC2 citations73
US10829533B2Nov 10, 2020
Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels
ACCELERON PHARMA INC1 citations73
US10227392B2Mar 12, 2019
ALK7:ActRIIB heteromultimers and uses thereof
ACCELERON PHARMA INC3 citations73
US10196434B2Feb 5, 2019
ALK4:ActRIIB heteromultimers and uses thereof
ACCELERON PHARMA INC3 citations73
US12258380B2Mar 25, 2025
ALK4:actriib heteromultimers and uses thereof
ACCELERON PHARMA INC0 citations62
US12024563B2Jul 2, 2024
ALK7 antagonists and uses thereof
ACCELERON PHARMA INC0 citations62
US11827689B2Nov 28, 2023
ALK7:ActRIIB heteromultimers and uses thereof
ACCELERON PHARMA INC0 citations62
US11168311B2Nov 9, 2021
Methods for treating anemia in a subject in need thereof
ACCELERON PHARMA INC0 citations62
US11162085B2Nov 2, 2021
Methods for treating anemia in a subject in need thereof
ACCELERON PHARMA INC0 citations62
US11155791B2Oct 26, 2021
Methods for treating anemia in a subject in need thereof
ACCELERON PHARMA INC0 citations62
SEEHRA JASBIR
3 patentsUS8216997B2Jul 10, 2012
Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators
SEEHRA JASBIR100 citations99
US8058229B2Nov 15, 2011
Method of increasing red blood cell levels or treating anemia in a patient
SEEHRA JASBIR97 citations99
US8703927B2Apr 22, 2014
Isolated nucleotide sequences encoding GDF traps
SEEHRA JASBIR57 citations98